Clinical Trial Update: CPET in CF Patients With One G551D Mutation Taking VX770 [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating CPET (cardiopulmonary exercise testing) in cystic fibrosis patients with one G551D CFTR mutation who are taking ivaca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Kalydeco (ivacaftor)

Snippet

Sponsor: The Alfred | Conditions: Cystic Fibrosis | Phase 4 | Status: UNKNOWN